BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 33846096)

  • 1. D-dimer at hospital admission for COVID-19 are associated with in-hospital mortality, independent of venous thromboembolism: Insights from a French multicenter cohort study.
    Chocron R; Duceau B; Gendron N; Ezzouhairi N; Khider L; Trimaille A; Goudot G; Weizman O; Alsac JM; Pommier T; Bory O; Cellier J; Philippe A; Geneste L; Ben Abdallah I; Panagides V; El Batti S; Marsou W; Juvin P; Deney A; Messas E; Attou S; Planquette B; Mika D; Gaussem P; Fauvel C; Diehl JL; Pezel T; Mirault T; Sutter W; Sanchez O; Bonnet G; Cohen A; Smadja DM;
    Arch Cardiovasc Dis; 2021 May; 114(5):381-393. PubMed ID: 33846096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D-dimer as a biomarker for assessment of COVID-19 prognosis: D-dimer levels on admission and its role in predicting disease outcome in hospitalized patients with COVID-19.
    Poudel A; Poudel Y; Adhikari A; Aryal BB; Dangol D; Bajracharya T; Maharjan A; Gautam R
    PLoS One; 2021; 16(8):e0256744. PubMed ID: 34437642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics and risk factors for symptomatic venous thromboembolism in hospitalized COVID-19 patients: A multicenter retrospective study.
    Li JY; Wang HF; Yin P; Li D; Wang DL; Peng P; Wang WH; Wang L; Yuan XW; Xie JY; Zhou F; Xiong N; Shao F; Wang CX; Tong X; Ye H; Wan WJ; Liu BD; Li WZ; Li Q; Tang LV; Hu Y; Lip GYH;
    J Thromb Haemost; 2021 Apr; 19(4):1038-1048. PubMed ID: 33534149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Routine Venous Thromboembolism Prophylaxis May Be Inadequate in the Hypercoagulable State of Severe Coronavirus Disease 2019.
    Maatman TK; Jalali F; Feizpour C; Douglas A; McGuire SP; Kinnaman G; Hartwell JL; Maatman BT; Kreutz RP; Kapoor R; Rahman O; Zyromski NJ; Meagher AD
    Crit Care Med; 2020 Sep; 48(9):e783-e790. PubMed ID: 32459672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of acute deep venous thrombosis in patients hospitalized for COVID-19.
    Riyahi S; Hectors SJ; Prince MR; Sweeney EM; Lane EG; Honya R; Margolis DJ
    Medicine (Baltimore); 2021 Sep; 100(38):e27216. PubMed ID: 34559112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Admission D-dimer levels, D-dimer trends, and outcomes in COVID-19.
    Naymagon L; Zubizarreta N; Feld J; van Gerwen M; Alsen M; Thibaud S; Kessler A; Venugopal S; Makki I; Qin Q; Dharmapuri S; Jun T; Bhalla S; Berwick S; Christian K; Mascarenhas J; Dembitzer F; Moshier E; Tremblay D
    Thromb Res; 2020 Dec; 196():99-105. PubMed ID: 32853982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D-dimer Level and Diabetes in the COVID-19 Infection.
    Miri C; Charii H; Bouazzaoui MA; Laouan Brem F; Boulouiz S; Abda N; Kouismi H; Bazid Z; Ismaili N; El Ouafi N
    Clin Appl Thromb Hemost; 2021; 27():10760296211045902. PubMed ID: 34590493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic assessment of venous thromboembolism in COVID-19 patients receiving thromboprophylaxis: incidence and role of D-dimer as predictive factors.
    Artifoni M; Danic G; Gautier G; Gicquel P; Boutoille D; Raffi F; Néel A; Lecomte R
    J Thromb Thrombolysis; 2020 Jul; 50(1):211-216. PubMed ID: 32451823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of venous thromboembolism in coronavirus disease 2019: An experience from a single large academic center.
    Rali P; O'Corragain O; Oresanya L; Yu D; Sheriff O; Weiss R; Myers C; Desai P; Ali N; Stack A; Bromberg M; Lubitz AL; Panaro J; Bashir R; Lakhter V; Caricchio R; Gupta R; Dass C; Maruti K; Lu X; Rao AK; Cohen G; Criner GJ; Choi ET;
    J Vasc Surg Venous Lymphat Disord; 2021 May; 9(3):585-591.e2. PubMed ID: 32979557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and laboratory characteristics of patients with novel coronavirus disease-2019 infection and deep venous thrombosis.
    Motaganahalli RL; Kapoor R; Timsina LR; Gutwein AR; Ingram MD; Raman S; Roberts SD; Rahman O; Rollins D; Dalsing MC
    J Vasc Surg Venous Lymphat Disord; 2021 May; 9(3):605-614.e2. PubMed ID: 33190816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venous thrombosis, thromboembolism, biomarkers of inflammation, and coagulation in coronavirus disease 2019.
    Thondapu V; Montes D; Rosovsky R; Dua A; McDermott S; Lu MT; Ghoshhajra B; Hoffmann U; Gerhard-Herman MD; Hedgire S
    J Vasc Surg Venous Lymphat Disord; 2021 Jul; 9(4):835-844.e4. PubMed ID: 33188961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arterial and venous thrombosis in coronavirus 2019 disease (Covid-19): relationship with mortality.
    Violi F; Ceccarelli G; Cangemi R; Cipollone F; D'Ardes D; Oliva A; Pirro M; Rocco M; Alessandri F; D'Ettorre G; Lichtner M; Pignatelli P; Ferro D; Ruberto F; Lip GYH; Pugliese F; Mastroianni CM;
    Intern Emerg Med; 2021 Aug; 16(5):1231-1237. PubMed ID: 34218413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of D-Dimer Testing in Predicting Recurrence in Elderly Patients with Unprovoked Venous Thromboembolism.
    Tritschler T; Limacher A; Méan M; Rodondi N; Aujesky D
    Am J Med; 2017 Oct; 130(10):1221-1224. PubMed ID: 28522384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coagulation parameters and venous thromboembolism in patients with and without COVID-19 admitted to the Emergency Department for acute respiratory insufficiency.
    Pizzi R; Gini G; Caiano L; Castelli B; Dotan N; Magni F; Virano A; Roveda A; Bertù L; Ageno W
    Thromb Res; 2020 Dec; 196():209-212. PubMed ID: 32911392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia.
    Palareti G; Legnani C; Cosmi B; Valdré L; Lunghi B; Bernardi F; Coccheri S
    Circulation; 2003 Jul; 108(3):313-8. PubMed ID: 12847064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism.
    Douketis J; Tosetto A; Marcucci M; Baglin T; Cushman M; Eichinger S; Palareti G; Poli D; Tait RC; Iorio A
    Ann Intern Med; 2010 Oct; 153(8):523-31. PubMed ID: 20956709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-adjusted D-dimer cut-off leads to more efficient diagnosis of venous thromboembolism in the emergency department: a comparison of four assays.
    Farm M; Siddiqui AJ; Onelöv L; Järnberg I; Eintrei J; Maskovic F; Kallner A; Holmström M; Antovic JP
    J Thromb Haemost; 2018 May; 16(5):866-875. PubMed ID: 29505695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers for the prediction of venous thromboembolism in critically ill COVID-19 patients.
    Dujardin RWG; Hilderink BN; Haksteen WE; Middeldorp S; Vlaar APJ; Thachil J; Müller MCA; Juffermans NP
    Thromb Res; 2020 Dec; 196():308-312. PubMed ID: 32977128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic role of D-dimer for in-hospital and 1-year mortality in exacerbations of COPD.
    Hu G; Wu Y; Zhou Y; Wu Z; Wei L; Li Y; Peng G; Liang W; Ran P
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2729-2736. PubMed ID: 27843309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of inflammatory and coagulation biomarkers for venous thromboembolism in COVID-19 patients.
    Hojker M; Tršan J; Tršan U; Gale A; Jerman A; Košuta D
    Clin Hemorheol Microcirc; 2023; 83(4):387-395. PubMed ID: 36683498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.